SKI Market

A+| A| A-|

Indian Indices

Sensex

77,155.62 347.14
( 0.45%)

Global Indices

Nasdaq

52,022.73 330.70
(0.64%)

Dow Jones

7,531.82 -43.47
(-0.57%)

Hang Seng

69,975.80 571.30
(0.82%)

Nikkei 225

10,504.45 73.83
(0.71%)

Forex

USD-INR

94.63 -0.29
(-0.31%)

EUR-INR

109.79 -0.04
(-0.03%)

GBP-INR

127.09 -0.16
(-0.13%)

JPY-INR

0.59 0.00
(-0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

855.7849313

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

38.04

60865.07

EPS(TTM)

Face Value()

Div & Yield %

56.7

0.12

Back

Precision Wires India standalone net profit rises 98.94% in the December 2025 quarter

Feb 14,2026

Net profit of Precision Wires India rose 98.94% to Rs 37.70 crore in the quarter ended December 2025 as against Rs 18.95 crore during the previous quarter ended December 2024. Sales rose 36.55% to Rs 1336.94 crore in the quarter ended December 2025 as against Rs 979.10 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1336.94	979.10	37
OPM %	5.64	4.09	-
PBDT	59.37	29.72	100
PBT	52.24	25.08	108
NP	37.70	18.95	99

77,155.62 347.14 ( 0.45%)

52,022.73 330.70 (0.64%)

7,531.82 -43.47 (-0.57%)

69,975.80 571.30 (0.82%)

10,504.45 73.83 (0.71%)

94.63 -0.29 (-0.31%)

109.79 -0.04 (-0.03%)

127.09 -0.16 (-0.13%)

0.59 0.00 (-0.29%)